Scientific and Planning Committee 5th GBHI Meeting

Mehul Mehta, Ph.D., U.S. Food and Drug Administration (co-chair)

Barbara S. Schug, Ph.D., SocraTec R&D GmbH (co-chair)

Gerald Beuerle, Ph.D., Teva

Erem Bilensoy, Hacettepe University

Henning Blume, Ph.D., SocraTec C&S GmbH

Jack Cook, Ph.D., Pfizer

Sebastian Haertter, Ph.D., Boehringer Ingelheim Pharma GmbH & Co. KG

Georg Hempel, Ph.D., University of Münster

Wenlei Jiang, Ph.D., U.S. Food and Drug Administration

Janet König, M.D., Bundesinstitut für Arzneimittel und Medizinprodukte

Andreas Kovar, Ph.D., Sanofi

Anne Seidlitz, Ph.D., University of Greifswald

Nilufer Tampal, Ph.D., U.S. Food and Drug Administration

Yu-Chung Tsang, Ph.D., Apotex

Jan Welink, Ph.D., Medicines Evaluation Board